Implementing a "publish, then review" model of publishing.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
01 12 2020
Historique:
received: 24 11 2020
accepted: 24 11 2020
entrez: 1 12 2020
pubmed: 2 12 2020
medline: 9 3 2021
Statut: epublish

Résumé

From July 2021 eLife will only review manuscripts already published as preprints, and will focus its editorial process on producing public reviews to be posted alongside the preprints.

Identifiants

pubmed: 33258772
doi: 10.7554/eLife.64910
pii: 64910
pmc: PMC7710353
doi:
pii:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2020, Eisen et al.

Déclaration de conflit d'intérêts

ME, DH, DW, MZ No competing interests declared

Auteurs

Michael B Eisen (MB)

eLife, Cambridge, United Kingdom.

Anna Akhmanova (A)

eLife, Cambridge, United Kingdom.

Timothy E Behrens (TE)

eLife, Cambridge, United Kingdom.

Diane M Harper (DM)

eLife, Cambridge, United Kingdom.

Detlef Weigel (D)

eLife, Cambridge, United Kingdom.

Mone Zaidi (M)

eLife, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH